Genetic mutations help brain tumors evade targeting by immunotherapy treatments

March 20, 2017

Tumors of the brain and spinal cord, or gliomas, are among the most commonly occurring brain tumors. Although a majority of gliomas are classified as curable, these low-grade tumors have the potential to develop more aggressive traits and become resistant to tumor-targeting approaches, including immunotherapy.

In a study published this week in the JCI, Hideho Okada's lab at UCSF investigated whether acquired mutations in the enzyme isocitrate dehydrogenase (IDH), which are common in low-grade gliomas, help these tumors become resistant to immunotherapy.

In both human astrocytes and mouse models of glioma, the IDH mutations impaired immune responses in the tumor environment by reducing the recruitment of T cells. Thus, the IDH mutations may help gliomas avoid anti-tumor targeting by therapies that rely on .

Importantly, inhibition of the mutant IDH enzyme enhanced the efficacy of a vaccine-based immunotherapy treatment in glioma-bearing mice. This finding suggests that combinatorial therapies may be able to counteract the effects of the IDH mutation to improve clinical responses to immunotherapy treatments for glioma.

Explore further: Attractive drug candidate identified to target glioma brain tumors

More information: Gary Kohanbash et al, Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI90644

Related Stories

Attractive drug candidate identified to target glioma brain tumors

December 15, 2016
In a paper published today in Cancer Research, researchers: 1) identify a biomarker enzyme associated with aggressive glioma brain tumors, 2) reveal the regulatory mechanism for that enzyme, and 3) demonstrate potent efficacy, ...

Histone deacetylase 6 inhibition enhances oncolytic viral therapy

October 20, 2015
Gliomas are extremely aggressive brain tumors that are resistant to standard cancer therapeutics. Oncolytic viral (OV) therapy, which uses engineered viruses to infect and target tumor cells for destruction by the immune ...

Signaling pathway suppresses brain tumors

December 4, 2015
Researchers at the University of Basel took a close look at a signaling pathway present in most organisms and found that it suppresses the formation of specific types of brain tumor. Their results have been published by the ...

Transplant drug could boost the power of brain tumor treatments

September 29, 2014
Every day, organ transplant patients around the world take a drug called rapamycin to keep their immune systems from rejecting their new kidneys and hearts. New research suggests that the same drug could help brain tumor ...

Genome-wide data can classify gliomas into subtypes

June 11, 2015
(HealthDay)—Genome-wide data can help classify subtypes of gliomas, according to two studies published online June 10 in the New England Journal of Medicine.

Researchers make breakthrough on immune system and brain tumors

September 27, 2012
In what could be a breakthrough in the treatment of deadly brain tumors, a team of researchers from Barrow Neurological Institute and Arizona State University has discovered that the immune system reacts differently to different ...

Recommended for you

Researchers develop test that can diagnose two cancer types

December 12, 2017
A blood test using infrared spectroscopy can be used to diagnose two types of cancer, lymphoma and melanoma, according to a study led by Georgia State University.

Cancer-causing mutation suppresses immune system around tumours

December 12, 2017
Mutations in 'Ras' genes, which drive 25% of human cancers by causing tumour cells to grow, multiply and spread, can also protect cancer cells from the immune system, finds a new study from the Francis Crick Institute and ...

Atoh1, a potential Achilles' heel of Sonic Hedgehog medulloblastoma

December 12, 2017
Medulloblastoma is the most common type of solid brain tumor in children. Current treatments offer limited success and may leave patients with severe neurological side effects, including psychiatric disorders, growth retardation ...

Drug suppresses spread of breast cancer caused by stem-like cells

December 12, 2017
Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, ...

MRI scans predict patients' ability to fight the spread of cancer

December 12, 2017
A simple, non-invasive procedure that can indicate how long patients with cancer that has spread to the brain might survive and whether they are likely to respond to immunotherapy has been developed by researchers in Liverpool.

Scientists discover possible master switch for programming cancer immunotherapy

December 11, 2017
During infection or tumor growth, a type of specialized white blood cells called CD8+ T cells rapidly multiply within the spleen and lymph nodes and acquire the ability to kill diseased cells. Some of these killer T cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.